TrialThe Journal of clinical investigation2020

Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.

Himisha Beltran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.